tazobactam has been researched along with gentamicin sulfate in 5 studies
Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (gentamicin sulfate) | Trials (gentamicin sulfate) | Recent Studies (post-2010) (gentamicin sulfate) |
---|---|---|---|---|---|
1,327 | 153 | 694 | 384 | 2 | 92 |
Protein | Taxonomy | tazobactam (IC50) | gentamicin sulfate (IC50) |
---|---|---|---|
30S ribosomal protein S6 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S7 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L15 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L10 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L11 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L7/L12 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L19 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L1 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L20 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L27 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L28 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L29 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L31 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L31 type B | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L32 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L33 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L34 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L35 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L36 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S10 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S11 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S12 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S13 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S16 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S18 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S19 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S20 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S2 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S3 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S4 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S5 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S8 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S9 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L13 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L14 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L16 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L23 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S15 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L17 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L21 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L30 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L6 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S14 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S17 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S1 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L18 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L2 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L3 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L24 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L4 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L22 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L5 | Escherichia coli K-12 | 0.028 | |
30S ribosomal protein S21 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L25 | Escherichia coli K-12 | 0.028 | |
50S ribosomal protein L36 2 | Escherichia coli K-12 | 0.028 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bonnet, R; Caniça, M; Ferreira, E; Manageiro, V; Mendonça, N; Robin, F; Salgado, MJ | 1 |
Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
Andlovic, A; Jeverica, S; Karisik, E; Koren, S; Krizan-Hergouth, V; Livermore, DM; Mesko Meglic, K; Müller-Premru, M; Palepou, MF; Pike, R; Seme, K; Woodford, N | 1 |
Kirikae, T; Kitao, T; Miyoshi-Akiyama, T | 1 |
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH | 1 |
5 other study(ies) available for tazobactam and gentamicin sulfate
Article | Year |
---|---|
The Lys234Arg substitution in the enzyme SHV-72 is a determinant for resistance to clavulanic acid inhibition.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Arginine; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Clavulanic Acid; Computer Simulation; Imipenem; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Lysine; Microbial Sensitivity Tests; Models, Molecular; Molecular Sequence Data; Penicillins; Protein Conformation; Protein Structure, Tertiary | 2008 |
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure | 2008 |
Nationwide survey of CTX-M-type extended-spectrum beta-lactamases among Klebsiella pneumoniae isolates in Slovenian hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovenia | 2009 |
AAC(6')-Iaf, a novel aminoglycoside 6'-N-acetyltransferase from multidrug-resistant Pseudomonas aeruginosa clinical isolates.
Topics: Acetylation; Acetyltransferases; Aminoglycosides; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrons; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2009 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea | 2010 |